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Pathophysiology of hemodynamically mediated acute renal fail-
ure in man. A tubular injury characterized by intraluminal ob-
struction and transtubular backleak of glomerular filtrate occurs
in experimental acute renal failure (ARF) in animals. To deter-
mine whether these alterations also occur in human ARF, we
studied 44 patients developing nonoligunc ARF following car-
diac surgery. The delay in appearance of iv. administered inulin
in urine (Ta) was used as a measure of tubular fluid flow rate. T
was not longer in 13 ARF patients than it was in control subjects
(7.2 vs. 9.0 mm), suggesting that at least a subpopulation of tu-
bules was widely patent. The fractional urinary dextran clear-
ance profile (OD; radii, 20 to 40 A) was then determined in 20
patients with sustained ARF in whom inulin clearance averaged
11 I mllminll .73 m2. A mass conservation model, which as-
sumes that 0D in Bowman's space in ARF is the same as that
measured in controls, when applied to the experimental observa-
tions revealed that, on the average, 42% of filtered inulin was lost
by transtubular backleak. A similar fractional inulin backleak
(38%) persisted in 11 additional patients in whom ARF had begun
to recover and in whom inulin clearance averaged 26 3 mllminl
1.73 m2. These findings suggest that in hemodynamically-mediat-
ed and nonoliguric ARF. (1) tubular obstruction is not homoge-
neous, and (2) backleak of glomerular filtrate contributes to but
does not fully account for depression of inulin clearance.
Physiopathologie de l'insuffisance rénale aiguë a mediation
hemodynamique chez l'homme. Une lesion tubulaire caractérisée
par l'obstruction intraluminale et la fuite trans-tubulalre de filtrat
glomCrulaire survient au cours de l'insuffisance rénale aigue
(ARF) experimentale chez l'animal. Afin de savoir si ces modifi-
cations surviennent aussi au cours de l'ARF humaine, 44 ma-
lades atteints d'ARF non oligurique au décours de la chirurgie
cardiaque ont ete étudiés. Le délai d'apparition dans l'urine de
l'inuline injectée par voie intraveineuse (Ta) a etC utilisC comme
mesure du debit tubulaire. T n'Ctait pas supCrieur chez 13 ma-
lades en ARF aux valeurs des contrôles (7,2 vs. 9,0 mm) ce qui
suggCre qu'au moms une sous-population de tubules Ctait large-
ment permeable. Le profit d'excrCtion fractionnelle de dextran(6; rayons, 20 a 40 A) a etC dCterminé chez 20 malades atteints
d'ARF chez lesquels Ia clearance de l'inuline Ctait en moyenne
de 11 1 ml . min/l,73 m2. Un modCle de conservation de Ia
masse, qui suppose que °D est le mCme dans l'espace de Bowman
que celui mesuré chez les contrôles, appliqué aux valeurs ex-
perimentales, montre qu'en moyenne 42% de l'inuline filtrée est
perdue par fuite trans-tubulaire. Une valeur semblable (38%) a
ete obtenue chez 11 autres malades chez lesquels Ia récupération
de l'ARF avait commence et dont Ia clearance de l'inuline Ctait
de 26 3 mI/mm/i ,73 m2. Ces constatations suggCrent que dans
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l'ARF a mediation hemodynamique et non oligurique (I)
l'obstruction tubulaire n'est pas homogene et (2) Ia fuite de filtrat
glomerulaire contnbue a Ia depression de Ia clearance de
l'inuline mais n'en rend pas compte totalement.
Our understanding of the pathophysiology of he-
modynamically mediated acute renal failure (ARF)
has largely derived from the study of experimental
animal models [1-4]. In these animal models, ARF
is induced by a transient but total interruption of
renal blood flow. Thereafter, a reversible ARF en-
sues that is characterized by a complex injury to the
renal microvasculature and tubules. During the pe-
riod of sustained ARF that follows the renal ischem-
ic insult, investigators have demonstrated a reduc-
tion of renal plasma flow [5, 6], a depression of the
glomerular ultrafiltration coefficient [7], and a tubu-
lar injury characterized by intraluminal obstruction
and backleakage of glomerular filtrate across the
tubular wall [8, 9]. Although fully 2 months may
elapse before renal function returns to normal, a
measurable increase in the clearance of inulin and a
reduction in azotemia have been detected by the
second week of this experimental renal injury [10-
12]. The chronology of events that herald this initial
improvement has not been clearly defined. Among
the factors associated with early recovery, how-
ever, are restoration of tubular impermeability to
inulin and an increase in both renal plasma flow and
glomerular ultrafiltration pressure [5, 10, 11, 13].
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Even though experimental models of ARF have
been designed to simulate human ARF, little direct
evidence is available to support the inference that
these models are analogous to the clinical entity. Of
the aforementioned pathophysiologic derange-
ments, only a reduction in renal plasma flow has
been directly demonstrated in human ARF 114—16].
Morphologic evidence of tubular injury is, how-
ever, frequently found [17—19]. This includes lumi-
nal cast formation and tubular dilatation that may
reflect tubular obstruction [18]. In addition, the
characteristic tubular cell necrosis is frequently ac-
companied by interstitial edema, which may result
from transtubular backleak of glomerular ultrafil-
trate [17].
To elucidate whether the pathogenesis of the he-
modynamically mediated ARF that follows cardiac
surgery in man resembles that following transient
ischemia in the experimental animal, we have (1)
measured inulin clearance and urinary solute excre-
tion at various times following the renal ischemic
insult, and (2) sought functional evidence of tubular
obstruction and backleak by studying the renal han-
dling of inulin and dextran 40, which are normally
excreted by glomerular filtration and neither reab-
sorbed nor secreted by the tubule. Our findings
form the basis of this report.
Methods
Patient population and clinical background. Us-
ing a protocol and consent procedure that had been
approved by the Committee on the Use of Human
Subjects in Research at Stanford University, we
studied 88 patients in the postoperative period fol-
lowing open heart surgery. Forty-four of these pa-
tients developed evidence of ARF, as judged by the
sudden onset of postoperative azotemia accom-
panied by isosthenuria, and increased fractional ex-
cretion of sodium (> 1%) and water (urine:plasma
inulin concentration ratio < 20) [20]. The remaining
44 patients, who remained normazotemic through-
out the postoperative period, served as controls.
Both ARF and control populations were character-
ized by advanced age, averaging 63 3 and 61
(sEM) 2 years, respectively. The surgical technique
and perioperative patient management, details of
which have been published elsewhere [21], were al-
so similar in the two groups. Of special relevance to
this study was the routine practice of infusing sub-
stances that lower renal vascular resistance and in-
crease urinary solute excretion throughout surgery
and the early postoperative period. These sub-
stances, which included 20% mannitol (intra-
operative), furosemide, and dopamine (postoper-
ative), are known to attenuate ARF in experimental
animals and have been termed protective agents
[22—25].
Study protocol. Patients with ARF were exam-
ined in three discrete stages during the course of the
renal injury. These were: (1) "evolving ARF,"
which was defined as the first 48 hours after the on-
set of increasing creatininemia; (2) "sustained
ARF," during which creatininemia of more than 48
hr's duration continued to increase progressively;
and (3) "recovering ARF," which followed sus-
tained ARF, and was characterized by a spontane-
ous and progressive decline in serum creatinine
concentration of 24 to 72 hr's duration. Twenty-
three patients were examined in two or three of the
aforementioned stages, so that in all, 71 studies
were performed in the 44 subjects with ARF.
All studies were performed when patients were
hemodynamically stable. Sudden changes in blood
volume, viscosity, and oncotic pressure were
avoided by withholding infusion of packed red cells,
hyperoncotic human albumin solution, and diuret-
ics for at least 6 hr prior to study. During each
study, fluid balance was maintained by constant in-
fusion of isotonic crystalloid solutions, and the in-
fusion rate of vasoactive drugs was held constant.
Radial arterial pressure was monitored via a saline-
filled catheter, which was connected to a Hewlett
Packard pressure transducer (model HP 1280). Car-
diac output was determined by injection of in-
docyanine green through a pulmonary arterial cath-
eter with subsequent analysis by a Waters densi-
tometer (model D-400) and Waters Cardiac Output
Computer (model CO-4). Following a priming dose
of 24 mg/kg of body weight, inulin was constantly
infused at approximately 6 mg/mm. After a 60-mm
equilibration period, three 20-mm urine collections
were made through an indwelling Foley catheter.
Arterial blood was drawn from the radial arterial
line to bracket each collection. From these plasma
and urine samples, the clearances of inulin, the frac-
tional excretion of sodium, and the urine-to-plasma
osmolality ratio were determined as previously re-
ported [26].
Special studies of tubular integrity: (a) Measure-
ment of inulin "blood-to-bladder" delay time.
Tubular obstruction in experimental ARF has been
found to result in a reduction in the rate of tubular
fluid flow [5, 13, 27]. In an attempt to detect this
phenomenon, we determined the blood-to-bladder
delay time of infused inulin (Ta).
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Following i.v. administration of inulin, there is a
delay in the appearance of inulin in the urine with
the result that inulin excretion first rises with time,
passes through a maximum, and then declines, ulti-
mately paralleling the plasma inulin concentration!
time curve (Fig. 1). This delay has been ascribed to
the existence of a well-mixed pool of urine, known
as the urinary dead space, which is comprised of the
renal tubules, pelves, and ureters [28, 29]. The
biexponential decay in plasma inulin concentration
following the i.v. injection of inulin is adequately
described by applying a two-compartment model
analysis to the vascular and interstitial spaces [30,
31]. If it be assumed that the renal tubules and col-
lecting systems contain a third (well-stirred) com-
partment of fixed volume receiving inulin by gb-
merular filtration, and losing it by excretion in the
urine, solution of the three-compartment problem
leads to the finding that
(T )1 — (T )-1(Tmax)1 ln[(T)/(T)] = [(T)—1, (TP)1]LM (1)
where (Tmax) is the time following inulin injection
when the urinary inulin excretion rate is maximal,
and T is the "mean residence time" (a good first
order approximation of the "blood-to-bladder delay
time") of inulin in the hypothesized urinary com-
partment (dead space). T0 is the mean residence
time of inulin in the plasma space at short times fol-
lowing inulin administration, and LM signifies loga-
rithmic mean.
To avoid technical difficulties inherent in measur-
ing urinary inulin excretion dynamics at low rates of
urine flow, we performed 25 studies (13 in sustained
ARF, 12 in control) when urine flow exceeded 1 mlI
mm. Urinary inulin excretion rate and plasma inulin
concentration were determined initially every 3 mm
and later (after 15 mm) every 5 mm throughout the
first 35 mm following i.v. injection of an inulin bolus
(24 mg/kg of body wt). T0 was calculated from the
tangent-slope of the log (plasma concentration) vs.
time curve at zero time. (Tmax) was determined from
the urinary inulin excretionltime curve (Fig. 1). T
was then solved using Equation 1.
The size in milliliters of the urinary compartment,
UPS, was then calculated from the equation
T = UPS/V
where V is the rate of urine flow in mllmin.
(b) Detertnination of fractional jim/in backleak-
age. In the normal kidney, inulin and uncharged
dextran molecules with Einstein-Stokes radii (r) up
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Fig. 1. Urinary inulin excretion/time curves for 13 patients with
acute renal failure (lower) and 12 controls (upper). The arrow
indicates the time at which inulin excretion reached a maximum
in each group.
to 44 A are excreted by glomerular filtration, and
neither secreted nor reabsorbed [32]. Although in-
ulin (r 13.5 A) is freely filtered, restriction to fil-
tration is evident for dextran molecules of r = 22 A
and greater. The glomerular sieving coefficient (0)
for a dextran molecule (D) of a specific size can be
determined, therefore, from its fractional urinary
clearance relative to that of inulin [33]. If, in ARF,
tubular damage were to permit passive leakage of
inulin from tubule fluid into the peritubular space,
and if dextran molecules larger than inulin, but still
small enough to permeate the glomerular capillary
membrane, were to be less rapidly lost by backleak-
age through the damaged tubular epithelium, frac-
tional urinary clearances for these dextran mole-
(2) cules would be substantially in excess of the true
sieving coefficient and could exceed unity. If it is
assumed that in ARF either the permeability prop-
erties of the glomerular capillary membrane are
identical to those of the normal gbomerulus, or that
any increase in transglomerular permeation of mac-
I I I
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I
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3
2
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Table 1. Hemodynamic findings and renal function in patients with acute renal failure (ARF)
Post-
operative
day
MAP
mm Hg
Cardiac
index
mi/minim2
Inulin
clearance
mi/minil.73 m2
Urine
flow
mi/mm
U/P
osmolality
U/P
inulin FEa
%
Controls (N = 44) 1.4 84 2796 85 1.6 1.94 85 1.1
AFR patients (N = 44)
a) evolving (n 23) 2.9 77e 2l00c 21C 10b i.isC 28C 1,5
b) sustained (n = 29) 6.8 79b 2468b 1OC 1.6 1.05C 9C 105b
c) recovering (n = 19) 8.9 80 3075 29c 1.5 1.29e 22e 1.4
a All results are expressed as means SEM. MAP is mean arterial pressure, FENa is fractional sodium excretion, and U/P is urine-to-
plasma ratio. N = no. of patients; n = no. of studies.
bP < 0.05, vs. controls.
ep < 0.005, vs. controls.
romolecules due to reduced plasma flow or ultrafil-
tration pressure is compensated by a decline in the
glomerular ultrafiltration coefficient [33], then it is
possible (using the control fractional dextran clear-
ance profile [O] and simple mass-conservation
constraints) to use the apparent fractional dextran
clearance profile (O) from patients with ARF to
estimate fractional backleak of inulin from the dam-
aged tubules. Based on this assumption, a detailed
theoretical analysis has been made and reported
elsewhere [26], the principal result of which is the
relationship:
Oapp (1 kD1) = 1 — kD,
(1 — k1) (1 — k1) (1 — k1) '
where 6 and 0 are defined above, and kD and
are the fractions of filtered dextran of the ith mo-
lecular radius and of inulin, respectively, lost from
the tubule. Now, k1 is a constant for a given pa-
tient, whereas kD is a function of the radius of the
ith dextran (rD). As rD. —* r1, kD1 —* k1; and as rD. —
, k — 0. Hence, a plot of (0app/0con) vs. r should
rise from a value of 1.0 (for small rD) to a maximum
limiting value of 1/(1 — k1) as r increases. Because,
as r—* , 0— 0, a plot Of(Oapp/Ocon) vs. 0rn should
permit a reasonably accurate extrapolation to the
limiting value of (Oappl6con) — 1/(1 — k1). Inasmuch
as the "true" GFR is equal to 1/(1 — k111) times the
"apparent" GFR (measured inulin clearance), the
GFR corrected for tubular backleak of inulin can be
calculated.
Accordingly, dextran 40 (130 mg/kg of body wt)
was administered to 31 patients with ARF (20 with
sustained and 11 with recovering ARF), and to 11
control patients by i.v. injection directly following
the priming injection of inulin. Dextran molecules in
plasma and urine from the first timed collection pe-
nod were separated into narrow 2-A fractions by
gel permeation chromatography [26]. Dextran con-
centration in each eluate was then determined by
the autoanalyzer anthrone method of Scott and
Melvin [34], and the fractional clearance of each
dextran fraction (OD) calculated by the equation
(4)
where (U/P)D and (U/P)1 are the urine-to-plasma
dextran and inulin concentration ratios, respective-
ly.
Statistical methods. Data for the control and
ARF patient groups were analyzed by means of the
Statistical Package for the Social Sciences [35]. A
two-tailed t test with separate variance estimates
was used to test the significance of the differences
observed. All results are expressed as the mean
SEM.
Results
Clinical and laboratory findings. The renal and
hemodynamic findings in 44 patients with ARF are
compared with those in 44 normazoternic controls
in Table 1. As shown, on the average, control pa-
tients and patients in the evolving stage of ARF
were examined in the early postoperative period
(first vs. second postoperative days), whereas pa-
tients with sustained and recovering ARF were
studied towards the end of the first and in the early
part of the second postoperative week, respective-
ly.
During the evolving stage of ARF, cardiac output
was profoundly depressed, mean cardiac index av-
eraging 2100 141 mllmin/m2 in 23 patients exam-
ined at this time. Simultaneous inulin clearance av-
eraged only 21 2 mllmin/1.73 m2, a value corre-
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sponding to only 25% of that in controls. Whereas
urine flow, and urine-to-plasma osmolality, and in-
ulin concentration ratios were significantly de-
pressed, fractional sodium excretion was not dif-
ferent from corresponding values in control sub-
jects.
Although cardiac performance remained de-
pressed in 29 patients examined during the sus-
tained stage of ARF, mean cardiac index had in-
creased to 2468 119 mllmin/m2. Notwithstanding
this improvement, renal function continued to dete-
riorate as judged by a decline in inulin clearance to
10 1 ml/min/1.73 m2, and in urine:plasma os-
molality and inulin concentration ratios to 1.05
0.01 amd 9 1, respectively. At this time, mean
fractional sodium excretion became strikingly ele-
vated at 10.5 3.6%, and urine flow increased from
initial values of 1.0 0.1 during the evolving stage
to 1.6 0.2 mllmin (P < 0.01). Thus, major impair-
ment of tubular function, typical of nonoliguric
ARF, was manifest during this stage of the renal in-
jury [36—38].
Only 21 of the 44 patients survived the stage of
sustained ARF. Of these, 19 were studied during
the early recovery stage. At this time, cardiac per-
formance had improved significantly, and values for
cardiac index were no longer different from those in
control patients (3075 123 vs. 2796 110 mI/mini
m2). Notwithstanding the equivalent cardiac per-
formance, inulin clearance remained profoundly de-
pressed, averaging only 34% of that in controls (29
3 vs. 85 3 mllmin/1.73 m2). As judged by a
slight but significant elevation above unity of
urine:plasma osmolality ratio (1.29 0.06) and by a
striking and significant reduction in fractional so-
dium and water excretion relative to sustained
ARF, partial recovery of tubular function was evi-
dent at this time.
Blood-to-bladder delay time (Ta) (Fig. 1, Table 2).
As shown in Fig. 1, mean inulin excretion rate
reached a maximum at approximately 12 mm in pa-
tients with sustained ARF and in control patients.
Furthermore, the excretion-time curves in these
two populations were qualitatively similar, the in-
ulin excretion rate being four to five times higher in
control subjects than it was in patients with ARF at
all times during the study.
T averaged 7.2 0.8 mm in patients with ARF, a
value not different from that in normazotemic con-
trols (9.0 0.9 mm), and similar to the 6 mm esti-
mated by Smith for normal man [28]. The estimated
urinary dead space was almost identical in patients
with ARF and in control patients, approximating 15
Table 2. Urinary inulin excretion dynamics in patients with acute
renal failure (ARF) and controls
V
ml!
mm
UDS
,nl T Tmax
mm
Inulin
clearance
ml/,nin/1.73m2
U/PthUljfl
Control
(N= 12) 1.8 14.9 9.0 12.5 83 68
ARF patients
(N= 13) 2.1 15.6 7.2 11.2
±0.8
14 7
P NS NS NS NS <0.001 <0.001
All results are expressed as means SEM. V is urine flow;
UDS, urinary dead space; T, blood-to-bladder delay time; Tmax,
time corresponding to maximum urinary inulin excretion
ml. Similarly, urinary flow did not differ significant-
ly between ARF and control patients in these stud-
ies (2.1 0.3 vs. 1.8 0.2 nil/mm). Thus, when
ARF is nonoliguric, the delay in the appearance in
the urine of i.v. administered inulin does not appear
to be prolonged. Because glomerular ultrafiltration,
the initial step in the process of urine formation,
was profoundly depressed in patients with ARF, the
attainment of a rate of urine flow equivalent to that
in normazotemic control patients resulted from a
striking reduction in the rate of tubular reabsorption
of water. This is reflected by the UIP11 ratio of 7
1 in these 13 ARF studies compared with 68 12
in 12 control studies (P < 0.001).
Fractional mu/in leakage (Figs. 2 and 3, Table 3).
In Fig. 2, the mean dextran clearance profile (Oapp)
for patients with ARF and control patients (6) are
plotted as a function of Einstein-Stokes radius of
dextran, rD interval, 20 to 40 A. As can be seen, 0app
for sustained ARF (Fig. 2a, left panel), was striking-
ly and significantly elevated above Orn for all dex-
tran fractions rD  22 A. In contrast to controls in
whom restriction to dextrans with r  22 A was evi-
dent, 0app remained close to unity for the dextran r
interval 22 to 28 A. Mean Oapp for the 11 patients
with recovering ARF (Fig. 2b, right panel) remained
elevated above O, over the dextran r interval 22 to
40 A. This response was more variable among indi-
vidual patients, however, such that statistical signif-
icance was only reached for dextran clearances
when r = 28 to 40 A. As with sustained ARF, Oapp
was close to unity in the dextran r range 22 to 28 A.
A plot of the ratios of the average values for 6a0p
to O for each stage of ARF as a function of control
fractional dextran clearances (Ocofl) is shown in Fig.
3. The correlation is nearly linear in the interval 1.0
> 0 > 0.2, and the limiting value 1/(1 — k1) of OappI
is estimated to be 1.77 and 1.60 for sustained
==
=
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Fig. 3. Mean fractional dextran clearance ratio (Oap3jOco,))
plotted as a function of control fractional dextran clearance
(000,) for 20 patients with sustained acute renal failure (ARF) (.)
and for II patients with recovering ARF (0).
and recovering ARF, respectively. From the prod-
uct of this quantity and the mean inulin clearance, a
true value for GFR of 19 and 42 mlJminJl.73 m2, re-
spectively, is obtained for the sustained and recov-
ering stages of ARF (Table 3). Accordingly, k10, the
2.0
1.8
1.6
1.4
1.2
1.0
Table 3. Fractional inulin backleak in patients
with acute renal failure with (ARF)
Inulin 1/1 —k True K105
clearance GFR
mi/mm mi/mm
Sustained ARF (N = 20) 11 1.77 19 0.42
Recovering ARF(N= II) 26 1.60 42 0.38
a — k is the limiting value of Oapp/Ocon vs. 0 (see text.)
K, is fractional inulin backleak ratio.
fraction of filtered inulin lost via leakage from dam-
aged tubules, averaged 42% in sustained ARF and
38% in recovering ARF.
Because there was considerable variability be-
tween the apparent fractional dextran clearance
profiles, the data for each study were plotted inde-
pendently in the manner of Fig. 3, and the individ-
ual limiting values 1/(1 — K1) of °aPP'0COn were com-
puted. The results of these extrapolations are sum-
marized in Table 4. In patients with sustained ARF,
1/(1 — K1) exceeded unity in all but one patient (no.
17) and varied between 1.2 and 3.4, indicating that
there may be considerable variability in the extent
of tubular damage, with the result that transtubular
inulin backleak, although substantial in most cases
(K1, 0.17 to 0.71), may vary by more than threefold
among individuals. During the early recovery phase
of ARF, 1/(1 — K1) exceeded unity, and K1 varied
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Fig. 2. Fractional dextran clearance profiles for patients with acute renal failure (ARF) and for controls. All results are expressed as the
means SCM. a (left panel) 0app for 20 patients with sustained ARF (.) is compared with in 11 post-cardiac surgical controls (s).
b (right panel) O, for 11 patients with recovering ARF (o) iscompared with 0 for the same 11 controls illustrated in panel a (fl).*P <
0.05, 0P <0.005, ARF vs. controls.
Discussion
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blood flow used to induce ARF in experimental ani-
mals. Nevertheless, the ensuing ARF in these two
situations is strikingly similar in many respects, in-
cluding the natural history of the lesion and the pat-
tern of urinary solute excretion [10, 12]. In the un-
protected experimental model, the rate of urine
flow and the clearance of inulin are depressed to a
greater extent than those found in our patients.
When, however, the experimental animal has been
pretreated with hypertonic mannitol, furosemide,
or certain renal vasodilators, ARF has been attenu-
ated into a nonoliguric form, which strongly resem-
bles the clinical entity encountered in this study [11,
22—25].
Our finding of a normal T should not be inter-
preted as indicating that tubular obstruction is not
functionally significant during the sustained stage of
this variety of ARF. There are at least two possible
_______________
explanations for a discrepancy between the appar-
ently rapid transit of inulin in our patients and the
prolonged tubular transit time found in post-
10 ischemic ARF in the rat [13]. In the latter injury,
10 tubular obstruction has been found to be extremely
variable between nephrons [5, 6]. It is likely, there-
7 fore, that the tubular injury in our patients was also
24 very heterogeneous, and that many tubules were to-
20 tally obstructed. Under these circumstances, T
10 will only reflect transit of inulin through a sub-
8 population of patent tubules. Because inulin clear-
ance (uncorrected for backleak) was only 17.5% of
38 that in control patients (Table 2), this subpopulation
11 might constitute a relatively small fraction of the to-
tal number of renal tubules, the remainder of which
14 may be totally obstructed. Furthermore, in an effort
18 to avoid artifacts in the determination of the inulin
excretion rate associated with low or changing uri-
nary flow [28], we studied T only in patients with
18 high and constant rates of urine flow. Proximal tu-
bule pressure has been found to be sixfold more ele-
vated when postischemic experimental ARF is un-
50 50 protected and oliguric than in protected and nonoli-
guric models [5, 6, 23]. Thus even in the unlikely
35 event that tubular injury is homogeneous, the p0-
11 11 tentially high velocity of tubular fluid flow in nonoli-
22 guric forms of ARF may, by flushing out tubular de-
26 42 bris, minimize tubular obstruction to a point where
30 60 it would not be detectable by the indirect method
used in this study.
Given the equally indirect method we have used
to arrive at a value for k1, it is interesting to note
that the magnitude of transtubular inulin backleak
in sustained human ARF is in good agreement with
the corresponding findings in the ARF following 60
mm of total ischemia in the rat [6, 9, 10, 13]. Our
calculation of k1 rests upon the assumption that the
between 0.17 and 0.67 in 8 of the 11 patients stud-
ied. When individually calculated values of 1/(1 —
K1) rather than mean °app for the entire group was
used to derive a mean value for K1, fractional inulin
leakage tended to be lower in recovering than in
sustained ARF (29 vs. 37%, Table 4). This dif-
ference, however, failed to reach statistical signifi-
cance.
The prolonged but partial renal ischemia induced
by poor cardiac performance in our patients differs
from the brief but complete interruption of renal
Table 4. Inulin leakage and clearances
in acute renal failure (ARF)
Pa-
tient 1/(1 -- K)
Inulin clearance,
,nl/min
Apparent True
Sustained ARF
1 2.4 0.60 4
2 1.2 0.20 8
3 1.3 0.25 12
4 1.7 0.41 10
5 3.4 0.71 2
6 2.0 0.50 12
7 1.4 0.32 0.3
8 1.4 0.30 14
9 1.3 0.20 8
10 2.1 0.30 4
11 1.7 0.40 15
12 1.4 0.30 19
13 1.9 0.47 20
14 1.8 0.45 6
15 1.9 0.50 4
16 1.8 0.43 8
17 1.0 0 14
18 1.2 0.17 15
19 1.8 0.45 31
20 1.8 0.44 15
1.73 0.37 11
Recovering ARF
21 1.0 0
22 1.2 0.17
23 1.0 0
24 1.4 0.29
25 1.0 0
26 1.9 0.48
27 2.1 0.50
28 1.6 0.38
29 2.0 0.50
30 1.2 0.18
31 3.0 0.67
1.58 0.29 26 42
Mean
SEM
Mean
SEM
P, sus-
tained
vs. re-
covery
a Abbreviations are defined in Table 3.
NS NS <0.005 <0.05
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transglomerular passage of dextrans in patients with
ARF does not differ substantially from that in con-
trol subjects; and hence, that the difference in frac-
tional dextran clearance profiles is due to trans-
tubular inulin backleak. Several of the determinants
of glomerular permselectivity to dextran macromol-
ecules do, in fact, become altered in experimental
ARF. Glomerular plasma flow and ultrafiltration
pressure decline [5, 8], which should increase the
permeation of dextrans into Bowman's space. Con-
versely, simultaneous depression of the glomerular
ultrafiltration coefficient [3, 7] would be predicted to
restrict transglomerular dextran permeation [39].
Our assumption, therefore, also requires that these
opposing determinants of macromolecule-sieving
offset one another. If this assumption is incorrect,
and the fractional clearance of dextrans into Bow-
man's space in ARF is substantially different from
that in controls, our estimate of k1 will clearly be
inaccurate. It is important to point out, therefore,
that 0D for two or more molecules in the r = 22 to 28
A exceeded unity in 11/20 and 6/11 of studies per-
formed in the sustained and early recovery stages of
ARF, respectively.
The mean fractional dextran clearance profile in
these selected 17 studies is illustrated in Fig. 4.
There are only two possible explanations for dex-
tran clearance exceeding inulin clearance in a ma-
jority (55%) of these consecutively studied patients
with ARF. The first of these requires that an altera-
tion in glomerular permeability properties or in cap-
illary hemodynamics permits larger dextran mole-
cules to permeate the glomerular capillary wall
more readily than do smaller inulin molecules (r =
13.5 A). It is, however, difficult to conceive how a
larger molecule could pass through the glomerulus
by passive forces at a faster rate than that for a small-
er molecule. Elevation of 0D above unity is better
reconciled, therefore, with the alternate explanation,
which is that smaller inulin molecules are leaking
back through the damaged tubular epithelium at a
rate more rapid than that for larger dextran mole-
cules, thus elevating the apparent fractional clear-
ance of dextrans above unity. This finding, which
was never observed in controls, provides strong
qualitative evidence in support of significant trans-
tubular backleak of glomerular ultrafiltrate in hu-
man ARF.
Sequential studies in postischemic experimental
ARF have demonstrated persistent inulin backleak
throughout the first week of ARF [5, 10, 13]. By the
end of the second week, however, transtubular
backleak was no longer evident, and inulin clear-
20 24 28 32 36 40
Einstein-Stokes radius, A
Fig. 4. Mean fractional dextran clearance profile in 17 of the 31
subjects with acute renal failure (ARF; A) selected because O in
the r = 22 to 30 A interval exceeded unity for two or more dex-
tran fractions. The fractional dextran clearance profile in con-
trols (L) is shown for comparison.
ance had improved [10, 13]. Our finding of per-
sisting inulin backleak in the face of increasing in-
ulin clearance in 8 of 11 patients during the first 3
days of recovering ARF in man suggests that one or
more of the determinants of glomerular ultrafiltra-
tion improve prior to restoration of tubular imper-
meability to inulin. The observed return of cardiac
performance into the normal range at this time
could, by increasing renal plasma flow or glomeru-
lar ultrafiltration pressure, account for the threefold
increase in inulin clearance associated with early re-
covery from ARF.
GFR, when corrected for backleak, averaged on-
ly 19 and 42 mllmin/1.73 m2 in the sustained and
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early recovery stages of ARF, respectively. Thus,
although inulin backleak contributes to the depres-
sion of inulin clearance in ARF, additional mecha-
nisms must be invoked to fully explain the depres-
sion of glomerular ultrafiltration observed in both
stages of ARF relative to control patients. It is pos-
sible, for example, that in spite of improving cardiac
performance, renal vascular resistance may have
been disproportionately elevated in patients with
ARF relative to control patients. In addition, a re-
duction in glomerular ultrafiltration pressure and/or
glomerular ultrafiltration coefficient, neither of
which can be determined in man, might contribute
to the glomerular hypofiltration observed in all
three stages of ARF. Our tentative conclusion,
therefore, is that this hemodynamically mediated
prototype of human ARF shares several patho-
physiologic similarities with its experimental coun-
terpart. These include (1) a transtubular inulin back-
leak, (2) a possible attenuation by diuretic and vaso-
dilator protective factors, and (3) an alteration in
one or more of the above determinants of glomeru-
lar ultrafiltration. These similarities appear to us to
enhance the relevance of currently used post-
ischemic experimental models of ARF. The poten-
tial to attenuate such ARF in the laboratory may,
therefore, yield information pertinent to developing
an effective therapeutic strategy for the human dis-
ease, which remains a highly lethal entity.
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